Navigation Links
How 'phenotype switching' can make melanoma become metastatic and resistant to drugs
Date:10/19/2013

One of the challenges of understanding cancer is trying to determine the mechanisms that drive metastasis, or the process by which tumor cells are able to spread throughout the body. In order to investigate metastasis, researchers at The Wistar Institute focused on a process involving the phenotypes the outward, physical appearance based on genetic coding of tumor cells. According to the researchers, "phenotype switching" may be involved in changing appearance of melanoma tumors by altering the number and type of protein receptors that dot the surface of the individual melanoma cells within the tumor. Identifying the phenotype patients exhibit may help determine which patients are more likely to benefit from existing medications while also providing an opportunity to create new targeted therapies.

The findings were published in the journal Cancer Discovery and are currently available online.

"We were able to demonstrate for the first time that different receptors within a single signaling pathway in this case, the Wnt signaling pathway can guide the phenotypic plasticity of tumor cells, and increased signaling of Wnt5A in particular can result in an increase in highly invasive tumor cells that are less sensitive to existing treatments for metastatic melanoma," said Ashani Weeraratna, Ph.D., assistant professor in the Tumor Microenvironment and Metastasis Program of Wistar's NCI-designated Cancer Center, and senior corresponding author on the manuscript.

While melanoma accounts for less than 5 percent of all cases of skin cancer, it is the deadliest form of the disease, resulting in a large majority of all the deaths related to skin cancer, according to the American Cancer Society. The five-year survival rate for patients with metastatic melanoma is between 15 and 20 percent, and while new, targeted therapies designed to combat the disease based on a person's genetics have become available in recent years, some of these d
'/>"/>

Contact: Ben Leach
bleach@wistar.org
215-495-6800
The Wistar Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. $1.5 million NCI Grant to aid Huntsman Cancer Institute researcher study melanoma, sun damage link
2. University of Houston engineering professor awarded grant to study melanoma treatment
3. AACR news: New target plus new drug equals death of melanoma cells
4. Gene mutation immortalizes malignant melanoma
5. Gene in eye melanomas linked to good prognosis
6. Serendipity points to new potential target and therapy for melanoma
7. Better approach to treating deadly melanoma identified by scientists
8. Fighting melanomas attraction to the brain
9. Should high-dose interleukin-2 continue to be the treatment of choice for metastatic melanoma?
10. New line of approach for combination therapy against melanoma
11. Why tumors become drug-resistant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2015)... , Feb. 24, 2015 This report analyzes the ... the following Segments: Face Biometrics, and Voice Biometrics. The report provides ... Japan , Europe , ... Africa , and Latin America ... through 2020. Also, a seven-year historic analysis is provided for these ...
(Date:2/19/2015)... , Feb .19, 2015 Research and ... the addition of the "Military Electro-Optical / ... Sensor Technology, by Platform - Forecast to 2020" ... The military electro-optical/infrared systems market is expected to ... CAGR of 7.71%. This report segments ...
(Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... early management of acute thoracolumbar spine and spinal cord ... treating trauma cases. To standardize the evaluation and treatment ... Spine and Spinal Cord Injury organized a group of ... Expert Consensus on the Evaluation and Treatment of Acute ...
... JOLLA, CADecember 22, 2013Scientists at The Scripps Research Institute ... payoffit enables the rapid selection of chemical compounds that ... how the compounds work. To illustrate the power ... to identify a compound that shows promise for treating ...
... that if mercury is high and increasing in fish in ... of fish elsewhere in the Arctic. But a team ... that assumption is wrong in much of the continental Arctic. ... result of diverse atmospheric, geological, and biological conditions, "It turns ...
Cached Biology News:Innovative screening strategy swiftly uncovers new drug candidates, new biology 2Innovative screening strategy swiftly uncovers new drug candidates, new biology 3Innovative screening strategy swiftly uncovers new drug candidates, new biology 4Virginia Tech research overturns assumption about mercury in the Arctic 2Virginia Tech research overturns assumption about mercury in the Arctic 3
(Date:2/27/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) ... of Trypsin" report to their offering. , ... providing comprehensive data on Trypsin globally and regionally ( ... North America , Latin America ... Trypsin This report focuses on three primary areas; ...
(Date:2/27/2015)... FamilyFarms Group is pleased to announce ... Line Farms, received the 2015 Tomorrow’s Top Producer Horizon ... age of 35, who has demonstrated excellence in the ... win the Tomorrow's Top Producer Horizon Award. Every year ... Producer Award and learning from their experiences. It is ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a significant ... Inc. in excess of $10 million. The jury determined ... and that it improperly hired one or more of ... for judgment notwithstanding the verdict, a new trial, and ...
(Date:2/26/2015)... PARK, Calif. , Feb. 26, 2015 ... released the latest version of the Governance Portal ... accomplish governance, risk and compliance (GRC) tasks across multiple ... also been updated to help customers better align their ... of the Treadway Commission ) requirements. In response to ...
Breaking Biology Technology:Global Market Report of Trypsin 2014-2018 2Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
... 24 /PRNewswire/ - Aegera Therapeutics Inc. is very,pleased ... and,financial executives to its Board of Directors: Mr. ... Managers Limited, and Mr. Gary,Littlejohn, Managing Director of ... experience and networks will be,critical for Aegera as ...
... Energizes National Medical Laboratory ... ... conjunction with,National Medical Laboratory Professionals Week (Lab Week), Abbott today,announced ... to engage and recruit young people to the clinical,laboratory profession, ...
... CardioVascular,BioTherapeutics, Inc. (OTC Bulletin Board: CVBTE) has entered into ... Derma Clinical Partners,(CDCP), an R&D Partnership. Mr. Frey, as ... and up to $5,000,000 of the clinical,development of CVBT,s ... successfully used in the past by some of,today,s biggest ...
Cached Biology Technology:Aegera Therapeutics welcomes two experienced executives to its board of directors 2Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners 2Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners 3Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners 4Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners 5CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership 2CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership 3
... developed specifically for pulsed field separations of DNA larger than 2, ... megabase pairs. This agarose has the highest gel ... ... Chromosomal Grade, ...
Anti-human VEGFR-2/KDR (Protein-A Purified) Polyclonal Antibody...
AVOID FREEZE/THAW CYCLES. Recognizes the UCP-2 protein....
... bridges the gap between the 500 l ... combines the speed of the classic Vivaspin ... area for superior recoveries from very dilute ... PES, Cellulose Triacetate membranes, Vivaspin 2 offers ...
Biology Products: